Supplementary Tables – Long-term safety and efficacy of bisphosphonate therapy in advanced lung cancer with bone metastasis

<strong>Supplementary Table 1</strong> - Safety and efficacy of bisphosphonate therapy Characteristics of patients in the PSM dataset. AE-free survivals of patients with two BP treatment patterns in different subtypes. The comparison was performed by the log-rank test. OS, overall survival; BP, bisphosphonate; AE, adverse event. <strong>Supplementary Table 2 -</strong> Safety and efficacy of bisphosphonate therapy Characteristics of patients between regular and irregular BP treatment groups. The Kaplan-Meier curves for SRE-free survivals of patients with regular and irregular therapy modes stratified by different OS and infusion times. Statistical analysis was performed using the log-rank test. OS, overall survival; BP, bisphosphonate; SRE, skeletal-related event.